{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T07:47:47Z","timestamp":1788940067756,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00125-014-3447-x","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T03:47:12Z","timestamp":1418096832000},"page":"575-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice"],"prefix":"10.1007","volume":"58","author":[{"given":"Clara Y.","family":"Westwell-Roper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus A.","family":"Chehroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather C.","family":"Denroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaques A.","family":"Courtade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Ehses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"3447_CR1","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2004-0405","volume":"89","author":"RL Hull","year":"2004","unstructured":"Hull RL, Westermark GT, Westermark P, Kahn SE (2004) Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab 89:3629\u20133643","journal-title":"J Clin Endocrinol Metab"},{"key":"3447_CR2","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356\u20132370","journal-title":"Diabetes"},{"key":"3447_CR3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00125-009-1410-z","volume":"52","author":"SJ Richardson","year":"2009","unstructured":"Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG (2009) Islet-associated macrophages in type 2 diabetes. Diabetologia 52:1686\u20131688","journal-title":"Diabetologia"},{"key":"3447_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tem.2009.12.010","volume":"21","author":"MY Donath","year":"2010","unstructured":"Donath MY, B\u00f6ni-Schnetzler M, Ellingsgaard H, Halban PA, Ehses JA (2010) Cytokine production by islets in health and diabetes: cellular origin, regulation and function. Trends Endocrinol Metab 21:261\u2013267","journal-title":"Trends Endocrinol Metab"},{"key":"3447_CR5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/icb.2014.4","volume":"92","author":"C Westwell-Roper","year":"2014","unstructured":"Westwell-Roper C, Nackiewicz D, Dan M, Ehses JA (2014) Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes. Immunol Cell Biol 92:314\u2013323","journal-title":"Immunol Cell Biol"},{"key":"3447_CR6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1126\/science.3086977","volume":"232","author":"K Bendtzen","year":"1986","unstructured":"Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans. Science 232:1545\u20131547","journal-title":"Science"},{"key":"3447_CR7","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1172\/JCI116129","volume":"90","author":"JA Corbett","year":"1992","unstructured":"Corbett JA, Wang JL, Sweetland MA, Lancaster JR, McDaniel ML (1992) Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide. J Clin Invest 90:2384\u20132391","journal-title":"J Clin Invest"},{"key":"3447_CR8","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.2337\/db13-0863","volume":"63","author":"CY Westwell-Roper","year":"2013","unstructured":"Westwell-Roper CY, Ehses JA, Verchere CB (2013) Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1beta production and beta cell dysfunction. Diabetes 63:1698\u20131711","journal-title":"Diabetes"},{"key":"3447_CR9","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.4049\/jimmunol.1002854","volume":"187","author":"C Westwell-Roper","year":"2011","unstructured":"Westwell-Roper C, Dai DL, Soukhatcheva G et al (2011) IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755\u20132765","journal-title":"J Immunol"},{"key":"3447_CR10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL et al (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes. Nat Immunol 11:897\u2013904","journal-title":"Nat Immunol"},{"key":"3447_CR11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cmet.2012.10.009","volume":"16","author":"T Mahdi","year":"2012","unstructured":"Mahdi T, Hanzelmann S, Salehi A et al (2012) Secreted frizzled-related protein 4 reduces insulin secretion and is overexpressed in type 2 diabetes. Cell Metab 16:625\u2013633","journal-title":"Cell Metab"},{"key":"3447_CR12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cmet.2013.05.001","volume":"17","author":"MY Donath","year":"2013","unstructured":"Donath MY, Dalmas E, Sauter NS, B\u00f6ni-Schnetzler M (2013) Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab 17:860\u2013872","journal-title":"Cell Metab"},{"key":"3447_CR13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2337\/diabetes.47.5.743","volume":"47","author":"WC Soeller","year":"1998","unstructured":"Soeller WC, Janson J, Hart SE et al (1998) Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide. Diabetes 47:743\u2013750","journal-title":"Diabetes"},{"key":"3447_CR14","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1128\/MCB.23.15.5293-5300.2003","volume":"23","author":"RA Waterland","year":"2003","unstructured":"Waterland RA, Jirtle RL (2003) Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23:5293\u20135300","journal-title":"Mol Cell Biol"},{"key":"3447_CR15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/diabetes.53.6.1509","volume":"53","author":"AE Butler","year":"2004","unstructured":"Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC (2004) Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 53:1509\u20131516","journal-title":"Diabetes"},{"key":"3447_CR16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/isl.2.2.11209","volume":"2","author":"M Hutton","year":"2010","unstructured":"Hutton M, Soukhatcheva G, Johnson JD, Verchere CB (2010) Role of the TLR signaling molecule TRIF in \u03b2-cell function and glucose homeostasis. Islets 2:104\u2013111","journal-title":"Islets"},{"key":"3447_CR17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00007890-200209270-00023","volume":"74","author":"PRO Salvalaggio","year":"2002","unstructured":"Salvalaggio PRO, Deng S, Ariyan CE et al (2002) Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation 74:877\u2013879","journal-title":"Transplantation"},{"key":"3447_CR18","doi-asserted-by":"crossref","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","volume":"38","author":"A Spandidos","year":"2010","unstructured":"Spandidos A, Wang X, Wang H, Seed B (2010) PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38:D792\u2013D799","journal-title":"Nucleic Acids Res"},{"key":"3447_CR19","doi-asserted-by":"crossref","first-page":"17144","DOI":"10.1074\/jbc.M110.210526","volume":"286","author":"A Ardestani","year":"2011","unstructured":"Ardestani A, Sauter NS, Paroni F et al (2011) Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization. J Biol Chem 286:17144\u201317155","journal-title":"J Biol Chem"},{"key":"3447_CR20","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1210\/en.2009-0708","volume":"150","author":"JS Harmon","year":"2009","unstructured":"Harmon JS, Bogdani M, Parazzoli SD et al (2009) Beta-cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db\/db mice. Endocrinology 150:4855\u20134862","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"3447_CR21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1463-1326.2012.01657.x","volume":"14","author":"J Montane","year":"2012","unstructured":"Montane J, Klimek-Abercrombie A, Potter KJ, Westwell-Roper C, Verchere CB (2012) Metabolic stress, IAPP and islet amyloid. Diabetes Obes Metab 14(Suppl 3):68\u201377","journal-title":"Diabetes Obes Metab"},{"key":"3447_CR22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2012.09.014","volume":"528","author":"GW Novotny","year":"2012","unstructured":"Novotny GW, Lundh M, Backe MB et al (2012) Transcriptional and translational regulation of cytokine signaling in inflammatory beta-cell dysfunction and apoptosis. Arch Biochem Biophys 528:171\u2013184","journal-title":"Arch Biochem Biophys"},{"key":"3447_CR23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-1-62703-523-1_2","volume":"1040","author":"C Westwell-Roper","year":"2013","unstructured":"Westwell-Roper C, Dunne A, Kim ML, Verchere CB, Masters SL (2013) Activating the NLRP3 inflammasome using the amyloidogenic peptide IAPP. Methods Mol Biol 1040:9\u201318","journal-title":"Methods Mol Biol"},{"key":"3447_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2006.12.187","volume":"354","author":"S Zraika","year":"2007","unstructured":"Zraika S, Hull RL, Udayasankar J et al (2007) Glucose- and time-dependence of islet amyloid formation in vitro. Biochem Biophys Res Commun 354:234\u2013239","journal-title":"Biochem Biophys Res Commun"},{"key":"3447_CR25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s001250051295","volume":"42","author":"DL MacArthur","year":"1999","unstructured":"MacArthur DL, de Koning EJ, Verbeek JS, Morris JF, Clark A (1999) Amyloid fibril formation is progressive and correlates with beta-cell secretion in transgenic mouse isolated islets. Diabetologia 42:1219\u20131227","journal-title":"Diabetologia"},{"key":"3447_CR26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/diabetes.52.2.372","volume":"52","author":"RL Hull","year":"2003","unstructured":"Hull RL, Andrikopoulos S, Verchere CB et al (2003) Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372\u2013379","journal-title":"Diabetes"},{"key":"3447_CR27","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1007\/s00125-014-3304-y","volume":"57","author":"DT Meier","year":"2014","unstructured":"Meier DT, Morcos M, Samarasekera T, Zraika S, Hull RL, Kahn SE (2014) Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice. Diabetologia 57:1884\u20131888","journal-title":"Diabetologia"},{"key":"3447_CR28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","volume":"53","author":"S Zraika","year":"2010","unstructured":"Zraika S, Hull RL, Verchere CB et al (2010) Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia 53:1046\u20131056","journal-title":"Diabetologia"},{"key":"3447_CR29","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC et al (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857\u2013865","journal-title":"Nat Immunol"},{"key":"3447_CR30","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1007\/s00018-012-1245-5","volume":"70","author":"A Gustot","year":"2013","unstructured":"Gustot A, Raussens V, Dehousse M et al (2013) Activation of innate immunity by lysozyme fibrils is critically dependent on cross-beta sheet structure. Cell Mol Life Sci 70:2999\u20133012","journal-title":"Cell Mol Life Sci"},{"key":"3447_CR31","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/me.2007-0028","volume":"21","author":"TA Matsuoka","year":"2007","unstructured":"Matsuoka TA, Kaneto H, Stein R et al (2007) MafA regulates expression of genes important to islet beta-cell function. Mol Endocrinol 21:2764\u20132774","journal-title":"Mol Endocrinol"},{"key":"3447_CR32","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00125-007-0712-2","volume":"50","author":"E Oetjen","year":"2007","unstructured":"Oetjen E, Blume R, Cierny I et al (2007) Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia 50:1678\u20131687","journal-title":"Diabetologia"},{"key":"3447_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1172\/JCI844","volume":"102","author":"M Arnush","year":"1998","unstructured":"Arnush M, Heitmeier MR, Scarim AL, Marino MH, Manning PT, Corbett JA (1998) IL-1 produced and released endogenously within human islets inhibits beta cell function. J Clin Invest 102:516\u2013526","journal-title":"J Clin Invest"},{"key":"3447_CR34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI200215318","volume":"110","author":"K Maedler","year":"2002","unstructured":"Maedler K, Sergeev P, Ris F et al (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851\u2013860","journal-title":"J Clin Invest"},{"key":"3447_CR35","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","volume":"106","author":"JA Ehses","year":"2009","unstructured":"Ehses JA, Lacraz G, Giroix M-H et al (2009) IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci U S A 106:13998\u201314003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3447_CR36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C (2008) IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 223:20\u201338","journal-title":"Immunol Rev"},{"key":"3447_CR37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11:633\u2013652","journal-title":"Nat Rev Drug Discov"},{"key":"3447_CR38","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db05-1566","volume":"55","author":"L Marzban","year":"2006","unstructured":"Marzban L, Rhodes CJ, Steiner DF, Haataja L, Halban PA, Verchere CB (2006) Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55:2192\u20132201","journal-title":"Diabetes"},{"key":"3447_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI6438","volume":"104","author":"K Hostens","year":"1999","unstructured":"Hostens K, Pavlovic D, Zambre Y et al (1999) Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J Clin Invest 104:67\u201372","journal-title":"J Clin Invest"},{"key":"3447_CR40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2337\/diabetes.50.3.534","volume":"50","author":"J Wang","year":"2001","unstructured":"Wang J, Xu J, Finnerty J, Furuta M, Steiner DF, Verchere CB (2001) The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes 50:534\u2013539","journal-title":"Diabetes"},{"key":"3447_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.53.1.141","volume":"53","author":"L Marzban","year":"2004","unstructured":"Marzban L, Trigo-Gonzalez G, Zhu X et al (2004) Role of beta-cell prohormone convertase (PC)1\/3 in processing of pro-islet amyloid polypeptide. Diabetes 53:141\u2013148","journal-title":"Diabetes"},{"key":"3447_CR42","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1210\/en.2004-1175","volume":"146","author":"L Marzban","year":"2005","unstructured":"Marzban L, Soukhatcheva G, Verchere CB (2005) Role of carboxypeptidase E in processing of pro-islet amyloid polypeptide in beta-cells. Endocrinology 146:1808\u20131817","journal-title":"Endocrinology"},{"key":"3447_CR43","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2337\/db05-1430","volume":"55","author":"K Maedler","year":"2006","unstructured":"Maedler K, Schumann DM, Sauter N et al (2006) Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes 55:2713\u20132722","journal-title":"Diabetes"},{"key":"3447_CR44","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/335632a0","volume":"335","author":"B Leighton","year":"1988","unstructured":"Leighton B, Cooper GJ (1988) Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335:632\u2013635","journal-title":"Nature"},{"key":"3447_CR45","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2007-1059","volume":"149","author":"NS Sauter","year":"2008","unstructured":"Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K (2008) The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149:2208\u20132218","journal-title":"Endocrinology"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3447-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-014-3447-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3447-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:53:51Z","timestamp":1558598031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-014-3447-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["3447"],"URL":"https:\/\/doi.org\/10.1007\/s00125-014-3447-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]}}}